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The role of ‘advocacy’ within public health attracts considerable debate but is rarely the subject of
empirical research. This paper reviews the available literature and presents data from qualitative
research (interviews and focus groups conducted in the UK in 2011e2013) involving 147 professionals
(working in academia, the public sector, the third sector and policy settings) concerned with public
health in the UK. It seeks to address the following questions: (i) What is public health advocacy and how
does it relate to research?; (ii) What role (if any) do professionals concerned with public health feel
researchers ought to play in advocacy?; and (iii) For those researchers who do engage in advocacy, what
are the risks and challenges and to what extent can these be managed/mitigated? In answering these
questions, we argue that two deeply contrasting conceptualisations of ‘advocacy’ exist within public
health, the most dominant of which (‘representational’) centres on strategies for ‘selling’ public health
goals to decision-makers and the wider public. This contrasts with an alternative (less widely employed)
conceptualisation of advocacy as ‘facilitational’. This approach focuses on working with communities
whose voices are often unheard/ignored in policy to enable their views to contribute to debates. We
argue that these divergent ways of thinking about advocacy speak to a more fundamental challenge
regarding the role of the public in research, policy and practice and the activities that connect these
various strands of public health research.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The idea that public health, by its very nature, entails advocacy,
appears to be ascendant. To take one example, a 2014 letter pub-
lished in the high-proﬁle medical journal, the Lancet, written by
ﬁve public health registrars, argued that ‘it is the duty of UK public
health institutions to advocate strongly for evidence-based mea-
sures to improve the health of society’ (Tillmann et al., p.213).
Whilst difﬁcult to gauge in quantiﬁable terms, searching the aca-
demic databases Web of Science for “public health” AND (advocacy
OR advocat*) in 2007e2016 returns over three times as many hits
as the previous decade.
The roots of this idea are long-standing. Rudolph Virchow, a
nineteenth century Prussian medic, famously argued that, for
medicine to accomplish its aims, ‘it must intervene in political and
social life’ to highlight ‘the hindrances that impede the normalith).
r Ltd. This is an open access articlesocial functioning of vital processes, and effect their removal’
(Virchow, 1985, p.33). More recently, public health frustrations
regarding deaths and other health harms arising from conﬂicts
(Shenoda et al., 2015), weak responses to pandemic disease out-
breaks (Timen et al., 2015), failures to tackle health inequalities
(Mackenbach, 2011) and cuts to health system ﬁnancing
(Karanikolos et al., 2013) have all been cited as evidence of the need
for advocacy. In some contexts (particularly the UK), the emphasis
that research funders have begun placing on ‘research impact’ has
provided further impetus for public health researchers to try to
achieve political and social inﬂuence (Greenhalgh and Fahy, 2015).
Yet, there has been little attempt within contemporary public
health to examinewhat advocacymeans in practical terms (Horton,
2012), who ought to be undertaking this kind of work or what
exactly it involves.
For those who promote the need for public health researchers to
engage in advocacy, the relationship between evidence and advo-
cacy is often assumed to be relatively straightforward; once sufﬁ-
ciently robust evidence is available, it can be used to advocate for
change (Tabak et al., 2015). Yet, Roberts (2009, p.46) argues thatunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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medicine due to the ‘heavy weight of conservatism’ and tradition in
the profession (see also Chapman, 2007). Indeed, the role of
advocacy in public health has often proved controversial. Even in
tobacco control, where the overlap between research and advocacy
has been particularly strong in recent years (Smith, 2013), Richard
Doll and Austin Bradford-Hill (who together helped demonstrate
the link between smoking and lung cancer (Doll and Hill, 1956)),
were extremely cautious about engaging in anything resembling
advocacy for much of their academic careers:
'At that time (1945e1960) I held the view, indeed I held it very
strongly, that the researcher faced with positive results, as we
were, had no part to play in telling the public about those re-
sults, and still less in how it should behave. Any education aimed
at changing habits must to some degree smack of propaganda
even in the best sense of that word … ' (Bradford-Hill, 1971,
p.57).
In an era of ‘knowledge exchange’, ‘public engagement’ and
‘research impact’ (Greenhalgh and Fahy, 2015), reservations about
simply ‘telling’ the public about research results seem almost un-
fathomable. However, other examples continue to court contro-
versy. Editor-in-chief of The Lancet, Richard Horton, has explicitly
stated that he aims ‘to use science as a political instrument to
promote social justice’ (Shalan, 2013; unpaginated) and has
attracted condemnation for his perceived ‘longstanding and wholly
inappropriate use of The Lancet as a vehicle for his own extreme
political views,’ (Professor Sir Mark Pepys, quoted in Wallis Simons,
2014). In response, Horton has argued that politics and health ‘go
hand-in-hand’ (Wallis Simons, 2014; unpaginated).
Against this backdrop, this article draws on existing literature
and qualitative data to ask the following questions: (i) What is
public health advocacy and how does it relate to public health
research?; (ii) What role (if any) do professionals concerned with
public health feel researchers ought to play in advocacy?; and (iii)
For those researchers who do engage in advocacy, what are the
risks and challenges and to what extent can these be managed/
mitigated? In answering these questions, we argue that two deeply
contrasting conceptualisations of ‘advocacy’ exist within public
health, the most dominant of which, ‘representational’, centres on
strategies for ‘selling’ public health goals to decision-makers and
the wider public. This way of thinking about advocacy closely re-
sembles ‘lobbying’. While valuable, particularly for public health
concerns that are currently under-represented in third sector
advocacy work (e.g. health inequalities), we argue that this
approach to advocacy can be rightly criticised as technocratic and
elitist. An alternative, ‘facilitational’ conceptualisation of advocacy
involves taking a more democratic approach to advocacy that
centres on listening to, and working with, communities and
members of the public whose voices are under-represented in
research and policy debates.
2. Methods
This article is based on (i) a literature review; and (ii) interviews
and focus group discussions with individuals involved in public
health research, policy and advocacy. For the literature review, we
identiﬁed existing academic publications concerning public health
advocacy by conducting systematic searches of relevant academic
databases. Our search terms included ‘public health’, ‘policy’,
‘advocacy’ and ‘research’ or ‘evidence’ (for precise search strings
and databases, see Web Appendix 1). In assessing relevance, we
focused on publications that either deﬁned public health advocacy
or commented on the role of research or researchers within it. Wedid not employ any date or methodological restrictions and
included essays and opinion pieces as well as empirical research.
However, due to resource limitations, we were only able to include
publications written in English. ES ﬁrst conducted this search in
May 2013, and then updated it in February 2014 (as we did not
include a historical cut off, the searches were intended to capture
all available literature in the included databases published up to
and including February 2014). Those publications considered to be
relevant on the basis of their title and abstract were downloaded to
a Zotero library. Once this had been completed for all ﬁve data-
bases, all duplicates were removed. The searches produced 129
relevant publications, whichwere reviewed in full. In this article we
draw on the 28 publications that we felt provided the most insights
into the questions posed in the Introduction, above.
In addition, 69 individuals involved in public health research,
policy and advocacy in the UK were interviewed between 2011 and
2013 and 90 individuals participated in focus groups, 12 of whom
were also interviewees (see Table 1). In total, this article is therefore
drawing on the perspectives of 147 individuals. Table 1 provides an
overview of the professional afﬁliation of these individuals. All of
the interviews were semi-structured and conducted by KS. The
majority took place in a private roomwhere, for the duration of the
interview, only the interviewee and the researcher were present
(one interview was a joint interview involving two interviewees
and two interviews were conducted by telephone, at the request of
interviewees). A themed interview schedule was employed which
focused questions around public health research, policy, advocacy
and knowledge exchange. The interviews varied in length, lasting
between 45 and 150 min (most were around 60e80 min).
Potential interviewees were selected on the basis of four
criteria: (1) their particular public health concern (most had some
interest in health inequalities but, beyond this, we tried to identify
individuals concerned with a range of issues, including tobacco,
alcohol and obesity); (2) their professional role (we tried to identify
individuals working on public health in academic, public sector,
third/community sector and private sector settings); (3) their role
in research and policy (we tried to include individuals who were
primarily undertaking research, individuals primarily undertaking
policy work and range of intermediaries, including individuals in
knowledge exchange andmedia roles); and (4) their perspective on
appropriate policy responses to health inequalities (here we tried
to include individuals who were known to favour more upstream,
radical policy responses and those favouring more meso- and
micro-level responses, though we found it harder to identify the
latter since there does now appear to be a fairly strong consensus
that upstream responses are required, at least among those with a
speciﬁc interest in reducing health inequalities).
Fifteen focus groups were also conducted, all of which lasted
around an hour (the topic guide for all focus groups was designed
by KS; facilitation was undertaken by a combination of the lead
author and colleagues (see acknowledgements), all of whom met
collectively to discuss the aims and approach in advance). One was
undertaken at a People's Health Assembly in Nottingham in 2012
and this focused explicitly on discussing ‘public health advocacy’. In
this focus group, which involved 15 participants, all of whom
identiﬁed themselves as public health advocates, participants were
asked to consider how to deﬁne public health advocacy, who they
believed did (and should) act as public health advocates and what
the relationship between research and advocacy ought to look like.
The other 14 focus groups were undertaken during a two-day
symposium held in Scotland in December 2012 at which partici-
pants (researchers, policymakers, civil society campaigners, public
health practitioners and research funders) were asked to explore
potential future directions for health inequalities research. The 14
focus groups were undertaken in two sets (seven focus groups in
Table 1
A summary of interviewees and focus groups participants.
Participants' primary professional self-identiﬁcation N interviewees 2011
e2013
N focus group participants 2012 Total
participating
Academic researchers 20 31 (*5) 46
Individuals working in policy and practice settings (e.g. civil servants and NHS staff) 15 12 (*2) 25
Researchers working in independent/private research organisation (including think
tanks)
1 0 1
Public sector researchers/policy advisors 3 13 (*3) 13
Journalists or media communications staff 1 0 1
Politicians (including ministers) 4 0 4
Research funders 4 3 7
Public health ‘knowledge brokers’ 3 5 (*1) 7
Senior staff in third sector organisations 18 7 (*1) 24
Public health/local community advocates 0 19 19
Total 69 90 (*12) 147
(N*) Indicates the number of focus group participants who were also interviewed in 2011e2013.
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participating in at least one (most participated in two). Although
these 14 focus groups did not explicitly focus on ‘public health
advocacy’, both the potential importance of public health advocacy
and the risks facing researchers who advocate were strong features
of these discussions.
All focus group discussions took place under the ‘Chatham
House rule’ enabling participants to share the content of discus-
sions with others only on a non-attributable basis. All participants
(for focus groups and interviews) were asked to sign written con-
sent forms enabling discussions to be digitally recorded and tran-
scribed, before being analysed (all interviewees were also given an
opportunity to check their transcripts for accuracy and anonymity).
All anonymised transcripts were coded by KS in NVivo 10 using a
thematic coding framework that she developed iteratively, via
analysis and re-analysis of the transcripts. The key thematic codes
(‘parent Nodes’ in NVivo) we developed were: academic freedom;
academic/research work; achieving policy/social change; advocacy,
knowledge exchange and impact; changes in academia; coalitions
and fractures in public health debates; credibility (of individuals,
research and ideas); idea types; morality and ethics; policy actors&
sectors; policy processes; politics; position on health inequalities
(causes and solutions); professional careers. The emerging themes
and ﬁndings were presented to audiences at conferences and
workshops that included some of the participants, enabling us to
test our interpretations. Participants' feedback largely supported
our interpretations but repeatedly drew particular attention to the
tension between ‘faciltiational’ and ‘representational’ forms of
advocacy in public health (without using those terms), leading us to
place more emphasis on this aspect of our analysis in this paper. All
research was approved by the University of Edinburgh's School of
Social & Political Science Ethics Committee in March 2011.3. Findings
Here, we draw on the multiple data sources to explain the key
ﬁndings. The concluding discussion then presents a reﬂexive
analysis of these ﬁndings.3.1. Varying deﬁnitions of public health advocacy
Most of the literature on public health advocacy is, as one of its
most enthusiastic promoters notes (Chapman, 2007), lacking in
empirical research; it is, instead, disproportionately composed of
editorials and comment pieces. This may explain both the paucity
of clear deﬁnitions and the lack of consensus where deﬁnitions do
exist. Only two of the publications we identiﬁed which reportempirical research on public health advocacy adopt clear deﬁni-
tions (Asbridge, 2004; Carr-Gregg, 1993), while interview and focus
group participants similarly provided a range of different accounts.
Table 2 provides an overview of commonways of deﬁning advocacy
across the literature and qualitative data. The ﬁrst column of Table 2
categorises deﬁnitions by the emphasis: processes, goals (agreeing
future-orientated types of change to achieve and working to ach-
ieve these) and outcomes (a more retrospective, evaluative means
of deﬁning public health advocacy as work that helped achieve
actual, health-positive change). Beyond this, three key variances in
the deﬁnitions emerge. First, while the practical, outcomes-focused
conceptualisation of public health advocacy evident in some sour-
ces (e.g. Carr-Gregg, 1993; Christoffel, 2000; Rock et al., 2011) im-
plies it is a form of work that can be monitored, perhaps even
evaluated, Chapman andWakeﬁeld speciﬁcally argue that advocacy
differs from traditional public health researchwork in that it cannot
be treated as an intervention and assessed for efﬁcacy (Chapman
and Wakeﬁeld, 2001). Second, while some deﬁnitions focus on
achieving upstream systemic or policy changes (Chapman, 2007;
Christoffel, 2000; Freudenberg, 2005), others (particularly in
North America), focus on altering ‘community level conditions’
including via health promotion (Avery and Bashir, 2003; Bassett,
2003), while others (e.g. Adshead and Thorpe, 2009 writing from
within the UK Department of Health) emphasise achieving indi-
vidual behavioural change.
Thirdly, as outlined above, there are two discernibly distinct
understandings of what public health advocacy entails. In
Chapman's (2007) terms, public health advocacy includes (amongst
other things) working to place and maintain issues on public and
political agendas (and exploiting opportunities to do so), discred-
iting opponents of public health objectives and working to frame
evidence in persuasive ways (e.g. via metaphors or analogies). In
other words, ‘advocacy’ involves strategically ‘selling’ pre-deﬁned
public health objectives to a range of non-academic audiences.
Carlisle describes this way of thinking about advocacy as ‘repre-
sentational’ (2000) and contrasts it with an alternative, more
community orientated ‘facilitational’ deﬁnition of advocacy (e.g.
Altman et al., 1994; Avery and Bashir, 2003; Bassett, 2003) which is
also evident in Table 2. This way of thinking about advocacy is more
akin to Burawoy’s (2005) notion of ‘public sociology’, in which re-
searchers engage in dialogue with members of the public and work
collaboratively with organisations representing public interests; it
involves working with relevant communities to ensure that voices
which might traditionally be ignored are given due regard.
The difﬁculties of deﬁning the boundaries of public health
advocacy are, then, a distinct feature of the literature. To some
extent advocacy (as presented by its proponents) seems to be a
Table 2
Quotes illustrating different emphases in deﬁnitions of public health advocacy.
Deﬁnition and example from literature review Illustrative quotes from qualitative data
Emphasis:
Process
Using evidence to push for changes in policy
and practice (Asbridge, 2004)
Researcher (interviewee): “[Blank e anti-poverty campaigning group] is a classic group for using research and
they're all academics on the steering group so it's not surprising that you would ﬁnd that [this organisation] is a
very research savvy organisation […] [which also has] really powerful links […] into the policy world.”
Coalition building (Christoffel, 2000) Focus group participant: “It's this way of using a, it is like creating a movement,”
Working with the media (Chapman, 2004) Public health practitioner who has held research, policy and advocacy roles: “[Public health advocacy] has a
very important policy role and [advocacy organisation] punches well above their weight, I think, because they
can produce statements which do get listened to by the media.”
Helping those who are not heard to have voice
(Carlisle, 2000)
Focus group participant: “[It's] being a voice for the people who can't speak”
Emphasis:
Goal
Countering corporate inﬂuence (Chapman,
2007; Freudenberg, 2005)
Researcher: “I actually do think that one [of the biggest issues] is corporate policy inﬂuences and we [researchers
and advocates] have got to get better at countering that”
Selling health (Chapman, 2007; Walsh et al.,
1993)
Focus group participant: “you've got to be conﬁdent in the fact that you've got to sell health as this fantastic
thing and you've got to sell it any way you can.”
Emphasis:
Outcomes
Achieving policy change (Carr-Gregg, 1993) Public health practitioner who has held research, policy and advocacy roles: “In the passage of the bill recently
[advocacy organisation] was mentioned a lot […] which is great. That shows that [the advocacy organisation] is
having some impact in terms of policy change.”
Achieving health-positive changes (Christoffel,
2000)
Focus group participant: “To me, being a public health advocate - you are changing something within your
community,”
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nonetheless, some areas of agreement. It seems clear, for a start,
that ‘advocacy’ involves something more than the widely accepted
model of researchers working in isolation or even in conjunction
with senior policymakers to try to develop evidence-informed
policy responses to public health problems (Petticrew et al.,
2004). Moreover, when it comes to thinking about the relation-
ship between public health research and advocacy and, speciﬁcally,
academic advocacy, some broadly consistent types of activities are
described, captured in Fig. 1, below.
The centre of Fig. 1 depicts ongoing parts of life in the academy
that go only a stage further than the ‘traditional scientist archetype’
described by interviewees in Haynes et al. (2011). Such activities
include working within NGOs to wield greater legitimacy and re-
sources (Caira et al., 2003; McGovern, 2007), actively seeking toFig. 1. The research-ainﬂuence policy development through strong relationships with
policymakers (Caira et al., 2003; Haynes et al., 2011) and offering
oneself as an ‘expert’ for commissions or advisory groups (Loue,
2004; Weed, 1994). While these kinds of activities reﬂect some of
the deﬁnitions of advocacy discussed above, they are also precisely
the activities that proponents of evidence-based policy tend to
encourage (e.g. Hunter, 2009; Lavis et al., 2009). The other three
groupings in Fig. 1 e planning, conducting and disseminating
research - relate to how advocacy might be located across speciﬁc
projects. With the exception of participatory research, most activ-
ities relate to the planning and dissemination stages. Those listed
under dissemination are relatively uncontroversial. Some, such as
presenting research ﬁndings to policymakers and politicians at
local, national or international levels (Okonofua et al., 2014;
Thornton et al., 2007), sit comfortably with the ‘traditionaldvocacy lifecycle.
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including the production of speciﬁc non-academic outputs such as
factsheets or toolkits (Hicks et al., 2012) or using personal narra-
tives and visual imagery to ‘sell’ research ﬁndings to media outlets
(Chapman, 2007; Rock et al., 2011).
The activities described under ‘planning research’, such as sur-
veys to demonstrate public support for a measure (Maina et al.,
2012), or work to show a particular ﬁeld is underfunded (and
under-researched) (Behague and Storeng, 2008), attract more
critical analysis, illustrating some of the tensions of advocacy-
centric research. To take two examples, Behague and Storeng
(2008; see also Storeng and Behague, 2014) describe researchers
searching for a single ‘testable’ intervention for maternal health to
attract attention and funding, with the consequence that wider
systemic changes were ignored, while Cruz and Walt (2013)
describe Gates Foundation funded researchers experiencing pres-
sure to ﬁnd evidence to support a particular malaria control
intervention in order to aid its policy adoption. These concerns
about research being shaped in particular directions in order to
have ‘real world’ impact (and closely relatedly) to advance re-
searchers careers, were also raised by our research participants.3.2. Competing views about the appropriate role of researchers in
public health advocacy
Whatever public health advocacy is, our interview and focus
group data suggest public health researchers, policymakers and
advocates often hold strong opinions about the appropriateness of
academics’ engagement in it. Focusing ﬁrst on areas of consensus:
everyone we interviewed appeared to believe that public health
researchers ought to be contributing to efforts to achieve social and
policy changes to the beneﬁt of public health. Most interviewees
also recognised that policies were shaped by the advocacy and
lobbying activities of different actors and suggested that policies,
and advocacy efforts to inform policies, could be strengthened
through engagement with research:
NGO staff member: “I suppose for me [effective public health
advocacy] comes back to having the evidence - we need to be able
to back up what we're trying to say.”
For some, these beliefs translated into an unequivocal view that
researchers working in this area faced a fundamental (in some
cases, moral) imperative to help achieve change:
Focus group participant (advocate): “I honestly don't see the point
of doing research unless we can try and implement the good points
that come out of that or the lessons that's learned from it …”
For others, however, the role of researchers (and speciﬁcally
academics) in advocacy was more questionable, as the following
sections of the paper explore. Some simply argued that professional
advocates (e.g. in NGOs) were better equipped/skilled to undertake
this kind of work:
Academic (interviewee): “I don't know if it's the role of academics,
in general, to be … using research for advocacy. […] In terms of
social skills, the people who work in NGOs often understand more,
however irritating meetings are, that actually being able to
get along with people and make relationships with people is
actually half the battle,”
There were also, however, obvious problems with the idea that
academics and other researchers ought to leave advocacy to others,particularly when it came to complex and cross-cutting public
health concerns for which prominent NGOs appeared lacking (e.g.
very few of our participants could name any organisations actively
campaigning to reduce health inequalities). This suggests that the
idea that researchers can simply feed their research ideas into
professional advocacy groups may not always be feasible and, in
these cases, there may be more of an impetus for researchers to
engage in advocacy more directly.3.3. Understanding and mitigating the risks and challenges of
researcher involvement in public health advocacy
For researchers working in public health who do take on
advocacy roles, whether that is because they have a strong,
evidence-informed commitment to a speciﬁc policy solution or
because they are concerned about a general lack of awareness
around a particular issue, it is clear that risks are involved. In this
section, we consider what those risks are, ﬁrst to academics and the
research they undertake, and next to the public health issues of
concern, before considering whether and how such risks might be
managed.3.3.1. The risks facing academic advocates
Across the literature and our qualitative data, four distinct
concerns emerge. The ﬁrst (and most common) was a broad
consensus around the tension between policymakers’ need for
clearly deﬁned proposals and the limitations of traditional aca-
demic research for developing such proposals:
Public health advocate (focus group participant): “Often re-
searchers focus on the problem and explaining the problem and
evidencing the problem, which you need, absolutely, but less
focused on solutions and less focused on what could be done about
it […] and that's actually really difﬁcult to take to politicians and
policymakers, because as soon as you take them a problem, they
want the solution.”
Similar comments were made in three different focus groups
and, in each case, this prompted an intense discussion about the
extent to which it is reasonable (or desirable) to expect academic
researchers to move beyond describing research ﬁndings to the
realm of making policy recommendations (concerns also evident in
the interview data). Generally, while almost all of our participants
seemed to accept that advocates need speciﬁc recommendations to
work with, several participants (mostly, though not exclusively,
academics) queried whether it was ethical or appropriate for aca-
demics to perform this role. The following extract represents one
such example:
Academic researcher (interviewee): “The ethical tension [when
making speciﬁc recommendations] is: how morally justiﬁed are we
in misrepresenting the evidence as part of our advocacy function?
[…] [From] minimising uncertainty, which we're very, very heavily
pressurised to do as soon as we enter the public sphere … to really
outright misrepresentations of the evidence, which I would argue
[various high proﬁle health inequalities researchers] do. […] I've
found very, very little guidance on it.’
The second, related concern, expressed by a smaller number of
interviewees was whether academics engaging in advocacy do so
for ideological, rather than empirical, reasons:
Academic (interviewee): “I ﬁnd advocacy a difﬁcult issue because
… the most passionate advocates tend to have a very particular
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onto what the evidence says is going on.”
In these cases, participants' concerns were not simply that ac-
ademic advocates might ‘go beyond’ the available research evi-
dence but that the research outputs these individuals produced
were so heavily shaped by their personal-political positions that
this undermined the credibility of their research:
Academic (focus group participant): “During [a collaborative
research project on health inequalities that interviewee was
involved in], they had two groups working with the same data who
came out with the opposite conclusions. And surprise, surprise,
[Professor X's] group came out saying Nordic welfare states had
lower inequality.”
Carr-Gregg suggests this occurs because advocacy derives from
“personal values and self-interest” more than “the ﬁndings from
science” (Carr-Gregg, 1993: p.36S). In previous work we have
argued that it is never possible to separate ‘objective research’ from
researchers' normative, ideological and ethical positions (Smith,
2013), but advocating strongly on the basis of them involves
reputational and intellectual risks. For example, Cruz and Walt
(2013) argue that, once a researcher has developed and expressed
a clear policy position, it can be difﬁcult to take a step-back and
consider other points of view, even as evidence evolves. Interest-
ingly, Australian researchers found that when research advocates
do not declare their moral positions, this could impact on the
effectiveness of their advocacy (Carey and Crammond, 2015).
A third evident concern is that engaging in signiﬁcant amounts
of advocacy work may compromise a researcher's actual and/or
perceived independence which, in turn, can reduce both their ac-
ademic and their policy credibility (Cruz and Walt, 2013; Haynes
et al., 2011; Rychetnik and Wise, 2004; Veerman et al., 2006).
Rychetnik and Wise (2004, p.253) argue that academics are valued
by policymakers precisely because they are ‘perceived to be inde-
pendent of the machinations that occur between competing policy
stakeholders, and thus untainted by the politics of policy devel-
opment. This means that, in working to try to increase the policy
and political relevance of their work, academics may actually un-
dermine a core aspect of their value in policy settings; a point
several interviewees also made:
Academic (interviewee): “I probably would want to strike a note
of caution [about academic advocacy] in that … as researchers,
there is probably a need to not only be independent but also be
perceived to be very independent.”
The data also make clear that academics who adopt public
media proﬁles risk criticisms and attacks from their peers. This was
less apparent for academics involved in tobacco control but most
academics working on health inequalities who were identiﬁed by
themselves and/or other academics as ‘advocates’ (or as academics
who engaged in advocacy work) were criticised on the basis either
that their recommendations were not sufﬁciently well supported
by research evidence or that they were egotistical and ‘liked being
on the telly’. Academics in this group were themselves very
conscious of this (see also Pickett and Wilkinson, 2016) and tended
to view it as a broader issue facing any academics engagingwith the
media or public:
Academic (interviewee): “I think it's often seen as sort of light-
weight, to go outside of academia, to engage with the public, that
it’s grandstanding or showing off or - I bet all historians don't likeSimon Schama. […] So I think it's often been seen as a bit egotistical
and not quite rigorous to go and do those kinds of things …”
Rychetnik and Wise (2004) also note that when researchers
adopt a clear policy position, it suggests that the available research
is sufﬁcient, limiting a researcher's ability tomake a case for further
research on this issue. Although none of our research participants
made quite this point, several senior academics acknowledged that
they beneﬁted from a context inwhich research and policy answers
were viewed as unclear:
Academic (interviewee): ‘In a way … it suits people like me to
have this phase of going round and round in circles because those
circles produce demand for research, which means people like me
can get funded, so our kind of every-day coping strategy is just to
think, ‘oh well, we won't complain while we're ahead. We won't…
look a gift horse in the mouth.’
Steve Fuller (2005) makes a similar point, noting that such a
situation not only beneﬁts academics in search of research income
but also politicians in search of reasons not to take action.
Finally, in more practical terms, several interviewees com-
plained that the sort of proactive, meticulously planned campaigns
undertaken by Chapman (2004) can be extremely time-consuming,
which invariably reduces the time available for more traditional
academic work (Haynes et al., 2011). A closely related concern is
that the focus expended on ‘translating’ research to connect with
community needs rather than academic discourse (Hicks et al.,
2012) might make it increasingly difﬁcult for researchers to
‘switch mode’ andmake the theoretical contributions still expected
(and rewarded) within the academy. For some, this was an issue
because they felt under pressure (for institutional and/or career
reasons) to focus on research outputs. For others, the issue was
more fundamental. One senior academic, for example, suggested
that academics whose work became ever-more policy focused,
risked losing ‘their links with the scientiﬁc stream of work, which
actually ensures the quality of what they do for policy.’3.3.2. The risks of academic advocacy for the public health issues of
concern
Many deﬁnitions of public health advocacy suggest that a key
aim is to attract public and/or policy attention to particular issues.
In this context, it might be assumed that working to ensure
research ﬁndings make their way into the public domain (through,
for example, media coverage) can be a useful way of advocating to
achieve policy inﬂuence (e.g. Veerman et al., 2006). Yet, in discus-
sing an example of a media campaign regarding food instability in
poor Canadian families, Rock et al. (2011) describe how unexpected
‘off-message’ reactions from members of the public meant that
public awareness of their research quickly became unhelpful for
policy change. Put bluntly, if research prompts a public backlash,
policymakers may feel constrained (rather than enabled) by
research-informed advocacy.
Although the speciﬁc example of media coverage of research
attractive negative public debate was not identiﬁed as a concern by
our own participants, there was quite a lot of debate about whether
public health advocacy should focus on trying to ‘educate’ and
‘inﬂuence’ the public or represent their views, reﬂecting Carlisle's
(2000) distinction between ‘representational’ and ‘faciltiational’
forms of advocacy introduced earlier:
Knowledge broker (focus group participant): “We are very good
at telling people what's good for them, rather than listening towhat
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transform public health in Scotland I think that's the way to go.”
This related to a broader risk of public health advocacy, identi-
ﬁed by two academic interviewees and an interviewee working for
an NGO, which was a concern that advocacy by 'expert' researchers
and large NGOs has the potential to be elitist and undemocratic.
The NGO policy advisor made this point in interview by giving an
example of attending a formal boardroom dinner with civil ser-
vants and academics who seemed oblivious at the irony of dis-
cussing inequality and participatory democracy in that setting.
All this poses a challenge to the idea that researchers and third
sector public health organisations should have any more inﬂuence
than they already do. Instead, the above three participants and the
focus group participant below suggested, researchers ought to
spend more time listening:
Academic (focus group participant): “How good are we at actu-
ally knowing, is the research community at knowing and under-
standing communities and working with communities? […] We
just don't - none of us do actually really listen.”
More practically, both the advice offered by experienced advo-
cates (Chapman, 2004) and empirical research on improving
evidence-based policy advice (Petticrew et al., 2004), suggest that
viable advocacy campaigns focus on ‘winnable issues’. To be
effective, this may mean putting more research effort into issues
which are ‘feasible’ or already on the policy agenda, and less on
those that seem too challenging for the current policy context:
Focus group participant (advocate/activist): “A lot of the argu-
ments we were making [were] about, this is an equity issue and all
the social determinants arguments. And when you present those in
a public forum, often what seems to happen is a kind of drawing
back, because people go, ‘well, that's just too huge, you're basically
asking us to change the whole structure of the economy […] so I
was trying to think […] whether you don't need some kind of two
pronged approach. One which is […] to come to policymakers with
quite concrete suggestions of things that can be done in the short
term …”
Yet, trying to agree concrete suggestions may reveal (or deepen)
divisions within a research community, with negative conse-
quences for the broader causes:
“The search for a single interventionwas not only reductionistic,
some argued, but contributed to inﬁghting and the constant
shifting of proposed vertical interventions … each vying for
policy attention. Such dynamics resulted in the splintering of
what could be a comprehensive community and facility-based
health systems approach into speciﬁc targeted sub-
components, or, as one policy expert described, isolated “bits of
the jigsaw puzzle.” (Behague and Storeng, 2008, p.645; see also
Cruz and Walt, 2013)
Finally, if researchers lose, or damage, their own credibility by
engaging in advocacy work (as described above), then any cam-
paigns associated with those researchers may also be damaged
(Veerman et al., 2006).3.3.3. Can the risks involved in academic advocacy be managed?
So far, we have identiﬁed a range of risks and dilemmas which
appear to recur for academics who engage in public health advo-
cacy and the causes for which they might advocate. Here, weconsider the two main strategies put forward for managing these
risks.
The ﬁrst is training; some risks may simply arise from poorly-
executed advocacy when, for example, researchers do not have
the right skill-sets for advocacy-orientated work (Rychetnik and
Wise, 2004). While some participants felt being appropriately
skilled at advocacy work was more a matter of personality, others
agreed with Chapman's (2007) case for advocacy training:
Academic (focus group participant): “I do think it's indefensible
that advocacy isn't a core public health competence. […] Lots of the
pressure for advocacy being integrated into the public health cur-
riculum has come from people like Simon Chapman who've long
argued that why is it that we're prepared to go on and make media
appearance without any training, but will sit down and rehearse a
conference paper that's going to be listened to by 20 people?”
From this perspective, this is a risk with the potential to be
managed, albeit requiring investment by universities, professional
organisations and others involved in public health training.
The other key recommendations for managing the risks of ac-
ademic advocacy involved working collaboratively:
Focus group participant (advocate/activist): “[Public health re-
searchers need to] make alliances and coalitions […] You see like
young academics getting nervous of saying things, and you think,
for goodness sake […], you're self-censoring yourself. And actually
it's not that dangerous if you go together, it's dangerous on your
own, you can get hit, but if you go together it's actually a really
strong force. And I think this country needs it right now.”
However, questions regarding the appropriate make up of
advocacy coalitions return us to the issue of democracy. Neither the
literature reviewed nor our interview data provided any clear
suggestions as to the appropriate role of different kinds of actors in
advocacy coalitions (particularly regarding leadership/coalition
formation) and the dearth of comments regarding the role of the
public was particularly noticeable. In the context of concerns about
declining public trust in experts (Saltelli and Giampietro, 2015), this
is a crucial challenge for those arguing for more public health
advocacy.3.4. Concluding discussion
The appropriate relationship between public health research
and advocacy, and the role of researchers within this, are long-
standing tensions subject to intense contemporary debate. The
ﬁndings presented here suggest that this debate is marked by
confusion as to what advocacy is and more fundamental dis-
agreements. On the one hand, if advocacy is understood in
Chapman's (2007) terms, many of the activities involved overlap
with those proposed in studies supporting evidence-informed
policymaking (Lavis et al., 2009) and research impact. From this
perspective, advocacy might be understood as representing a sec-
tion of work on a continuum between ‘ivory tower’ academia and
fully ﬂedged (often self-identiﬁed) advocacy and activism, inwhich
the role of research is secondary to the advocacy aims, as depicted
in Fig. 2.
Although our ﬁndings suggest that there is an ongoing debate
within public health as to the most appropriate (and desirable)
location for researchers on this spectrum, we are clearly a long way
from the era in which Bradford-Hill (1971) reﬂected that even basic
disseminationmight be perceived as ‘propaganda’. Indeed, virtually
all of our participants were somewhere to the right of Fig. 2 and
Fig. 2. Dissemination to Advocacy continuum.
Fig. 3. How participants depicted facilitational and representational advocacy and
associated activities.
K.E. Smith, E.A. Stewart / Social Science & Medicine 189 (2017) 35e4342there was a clear appetite for more discussion and guidance
(especially for earlier career researchers) as to how best to manage
competing tensions at this end of the spectrum. This included: a
desire to better understand how to support advocacy work with
research while avoiding the politicisation of research; an aspiration
to better understand the skills and resources required for advocacy
work; and some discussion as to how such demands might be
balanced with more traditional research career demands. In other
words, there is a desire to incorporate better understandings of
advocacy into public health training.
On the other hand, our ﬁndings also identiﬁed examples of very
different interpretation of advocacy, reﬂecting Carlisle's (2000)
contrast between ‘representational’ and ‘facilitational’ advocacy.
So, while most participants (and most of the literature) focused on
representational advocacy, others made a strong case for more
facilitational approaches, involving ‘listening’ and ‘working with’
communities. Perhaps the closest our participants came to over-
coming this tension was in suggesting that advocacy requires co-
alitions of different types of actors, though even here the role of the
public remained largely undiscussed. For the most part, in both the
literature and qualitative data, where the need to ‘engage’ the
public was mentioned it was depicted as a means of increasing
support for pre-deﬁned policy or social changes (based on research
evidence) rather than a means of opening up the evidence itself for
public debate (let alone dispute). This neglects both the widely-
argued advantages of publicly-engaged research, such as mobilis-
ing ‘lay’ knowledges for more socially-appropriate and acceptable
solutions (Cunningham-Burley, 2006), and the repeatedly identi-
ﬁed failings of top-down scientiﬁc dissemination (Wynne, 2006).
Facilitational advocacy does not, however, provide easy solutions:
unless researchers attempt to work in collaborationwith the whole
population, they will inevitably be amplifying some voices at the
expense of others (since it is usually only undertaken for small or
speciﬁc groups).
The potential overlap between these different approaches is
depicted at the centre of Fig. 3. The size of circles in Fig. 3 represents
an approximation of the frequency with which this approach
emerged in our data, while their relative position represents the
degree of overlap between the different concepts. Importantly,
none of our participants made suggestions that could be located at
the point in which all four circles overlap, where we might hope
strategies for overcoming the seemingly fundamental tension be-
tween facilitational and representational advocacy to exist. Indeed,
there are few obvious ways to address this tension, which essen-
tially concerns the tension between ‘selling’ evidence-informed
health proposals and more democratic ideals. Efforts to date, such
as public or ’lay’ representation on expert-led decision-making
committees, have been criticised for failing to: (i) engage a sufﬁ-
ciently wide range of people (Abelson et al., 2003); and (ii)
acknowledge the validity of people's experiential expertise
(Stewart, 2016).
If we are to progress beyond this tension, a more dialogic, less
top-down conceptualisation of public health advocacy seems
worth exploring. Many of the changes implied by public health
research demand national-level (often state-led) action; publichealth advocacy needs to be effective. As such, we ﬁnd the
normative case for both representational and facilitational advo-
cacy compelling (a preference which undoubtedly reﬂects our own
ethical and political commitments as scholars). There is now a
pressing need for more research to understand whether the
empirical case for facilitational advocacy lives up to the normative
one, and this might entail working to better understand links be-
tween ‘representational’ and ‘facilitational’ forms of public health
advocacy, especially as it seems unreasonable to expect the same
individuals to be skilled at both. This paper's efforts towards deﬁ-
nitional clarity within the ﬁeld are, we hope, a ﬁrst step towards a
stronger evidence base for these important practices.Acknowledgements
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